SCHEMBL14720215

SCHEMBL14720215

CC(C)(C)[N+]1(C(=O)O)CC[C@@H](CNc2cnccn2)C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2B Q13224 2/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
ALDH1A1 P00352 3/20 0.36
KDM4E B2RXH2 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
HPGD P15428 2/20 0.35
RAB9A P51151 4/20 0.35
KDM4C Q9H3R0 3/20 0.35
NPC1 O15118 3/20 0.35
TP53 P04637 1/20 0.35
MAPT P10636 1/20 0.35
NFKB1 P19838 1/20 0.35
NFKB2 Q00653 1/20 0.35
RELA Q04206 1/20 0.35
CHRM3 P20309 1/20 0.35
KMT2A Q03164 2/20 0.34
MEN1 O00255 1/20 0.34
PIM2 Q9P1W9 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14720167 0.81 CYP3A4 (0.46) GRIN2BCYP3A4CYP2D6CYP2C9ALDH1A1
SCHEMBL10293554 0.71 CYP2D6 (0.51) GRIN2BCYP3A4CYP2D6CYP2C9ALDH1A1
SCHEMBL14720339 0.70
SCHEMBL14720494 0.70 LMNA (0.33) CHRM3LMNA
SCHEMBL14720480 0.68 GRIN2B (0.61) GRIN2BCYP3A4CYP2D6CYP2C9ALDH1A1
SCHEMBL20474411 0.67 CYP3A4 (0.48) GRIN2BCYP3A4CYP2D6CYP2C9ALDH1A1
SCHEMBL13326499 0.67 GRIN2B (0.57) GRIN2BCYP3A4CYP2D6CYP2C9KDM4E
SCHEMBL1225401 0.65 CDK9 (0.48) GRIN2BCYP3A4CYP2D6CYP2C9ALDH1A1
SCHEMBL13326502 0.64 CDK4 (0.44) GRIN2BCYP3A4CYP2D6CYP2C9ALDH1A1
SCHEMBL14720415 0.64 DRD2 (0.38) ALDH1A1KDM4EHPGDRAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013028445-A1 FATTY ACID SYNTHASE INHIBITORS GLAXOSMITHKLINE LLC (US) 2013-02-28 WO disclosed